FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800876720> ?p ?o ?g. }

• W2800876720 endingPage "838" @default.
• W2800876720 startingPage "830" @default.
• W2800876720 abstract "Background Despite disparities in prostate cancer incidence and mortality rates between black and white men, there is still insufficient data available to assess potential differences in the benefits and harms of prostate cancer screening by race. Although the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial is underpowered to detect a difference by race in prostate‐cancer specific mortality, because of the large study size, there are still sufficient numbers to examine secondary screening outcomes. The objective of this analysis is to examine whether differences exist between black and white participants with respect to screening false‐positive rates, biopsy follow‐up of men with positive screens, tumor characteristics, and overdiagnosis of prostate cancer. Methods Participants from the PLCO included men aged 55‐74 years at baseline. Cancer diagnoses and deaths were identified through study update questionnaires, records of biopsy procedures, and linkage with the National Death Index. Cancer characteristics were obtained by medical abstractors. We used chi‐squared tests to assess differences in false‐positive rates, biopsy follow‐up, and tumor characteristics. We used Cox proportional hazards models to compare incidence and mortality rates adjusting for age and survival rates adjusting for Gleason scores. Results Black men were slightly more likely (14.5%) to have a false‐positive PSA test compared to white men (12.4%; P = 0.02) but less likely to have a false‐positive digital rectal exam (DRE) (10.9% vs 14.2%, respectively; P < 0.001). Among all men who were screened, black men were significantly more likely to undergo a biopsy than white men (16.5% vs 13.8%, respectively [ P = 0.003]) but there was no difference when limited to those with a positive PSA test. Prostate cancer tumors were more likely to be aggressive and to have metastasized in black men compared to white men. Disparities in incidence, mortality, and survival rates were comparable to those seen in population‐based data. Conclusions There was evidence that false‐positive test results differed by race and screening test. Consistent with previous studies, cancer outcomes, and tumor characteristics were all more unfavorable in black men." @default.
• W2800876720 created "2018-05-17" @default.
• W2800876720 creator A5022848290 @default.
• W2800876720 creator A5053628150 @default.
• W2800876720 creator A5064396212 @default.
• W2800876720 creator A5074755899 @default.
• W2800876720 creator A5086081364 @default.
• W2800876720 date "2018-04-17" @default.
• W2800876720 modified "2023-09-27" @default.
• W2800876720 title "Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial" @default.
• W2800876720 cites W1485235179 @default.
• W2800876720 cites W1548525621 @default.
• W2800876720 cites W1560543586 @default.
• W2800876720 cites W1973198827 @default.
• W2800876720 cites W1981042128 @default.
• W2800876720 cites W1997268744 @default.
• W2800876720 cites W2002371187 @default.
• W2800876720 cites W2022782430 @default.
• W2800876720 cites W2070301254 @default.
• W2800876720 cites W2079967558 @default.
• W2800876720 cites W2099969339 @default.
• W2800876720 cites W2109046819 @default.
• W2800876720 cites W2110733906 @default.
• W2800876720 cites W2113451181 @default.
• W2800876720 cites W2117090889 @default.
• W2800876720 cites W2117792530 @default.
• W2800876720 cites W2133152817 @default.
• W2800876720 cites W2134793522 @default.
• W2800876720 cites W2139566281 @default.
• W2800876720 cites W2168133848 @default.
• W2800876720 cites W2346441949 @default.
• W2800876720 cites W2415152805 @default.
• W2800876720 cites W2531626165 @default.
• W2800876720 cites W2558726901 @default.
• W2800876720 cites W2560292269 @default.
• W2800876720 cites W2598084316 @default.
• W2800876720 cites W2609553042 @default.
• W2800876720 doi "https://doi.org/10.1002/pros.23540" @default.
• W2800876720 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29667217" @default.
• W2800876720 hasPublicationYear "2018" @default.
• W2800876720 type Work @default.
• W2800876720 sameAs 2800876720 @default.
• W2800876720 citedByCount "20" @default.
• W2800876720 countsByYear W28008767202018 @default.
• W2800876720 countsByYear W28008767202019 @default.
• W2800876720 countsByYear W28008767202020 @default.
• W2800876720 countsByYear W28008767202021 @default.
• W2800876720 countsByYear W28008767202022 @default.
• W2800876720 countsByYear W28008767202023 @default.
• W2800876720 crossrefType "journal-article" @default.
• W2800876720 hasAuthorship W2800876720A5022848290 @default.
• W2800876720 hasAuthorship W2800876720A5053628150 @default.
• W2800876720 hasAuthorship W2800876720A5064396212 @default.
• W2800876720 hasAuthorship W2800876720A5074755899 @default.
• W2800876720 hasAuthorship W2800876720A5086081364 @default.
• W2800876720 hasConcept C120665830 @default.
• W2800876720 hasConcept C121332964 @default.
• W2800876720 hasConcept C121608353 @default.
• W2800876720 hasConcept C126322002 @default.
• W2800876720 hasConcept C143998085 @default.
• W2800876720 hasConcept C2775941076 @default.
• W2800876720 hasConcept C2776235491 @default.
• W2800876720 hasConcept C2776463041 @default.
• W2800876720 hasConcept C2779377019 @default.
• W2800876720 hasConcept C2779466945 @default.
• W2800876720 hasConcept C2780192828 @default.
• W2800876720 hasConcept C2781217009 @default.
• W2800876720 hasConcept C2781406297 @default.
• W2800876720 hasConcept C29456083 @default.
• W2800876720 hasConcept C61511704 @default.
• W2800876720 hasConcept C71924100 @default.
• W2800876720 hasConceptScore W2800876720C120665830 @default.
• W2800876720 hasConceptScore W2800876720C121332964 @default.
• W2800876720 hasConceptScore W2800876720C121608353 @default.
• W2800876720 hasConceptScore W2800876720C126322002 @default.
• W2800876720 hasConceptScore W2800876720C143998085 @default.
• W2800876720 hasConceptScore W2800876720C2775941076 @default.
• W2800876720 hasConceptScore W2800876720C2776235491 @default.
• W2800876720 hasConceptScore W2800876720C2776463041 @default.
• W2800876720 hasConceptScore W2800876720C2779377019 @default.
• W2800876720 hasConceptScore W2800876720C2779466945 @default.
• W2800876720 hasConceptScore W2800876720C2780192828 @default.
• W2800876720 hasConceptScore W2800876720C2781217009 @default.
• W2800876720 hasConceptScore W2800876720C2781406297 @default.
• W2800876720 hasConceptScore W2800876720C29456083 @default.
• W2800876720 hasConceptScore W2800876720C61511704 @default.
• W2800876720 hasConceptScore W2800876720C71924100 @default.
• W2800876720 hasFunder F4320332161 @default.
• W2800876720 hasIssue "11" @default.
• W2800876720 hasLocation W28008767201 @default.
• W2800876720 hasLocation W28008767202 @default.
• W2800876720 hasOpenAccess W2800876720 @default.
• W2800876720 hasPrimaryLocation W28008767201 @default.
• W2800876720 hasRelatedWork W1570285055 @default.
• W2800876720 hasRelatedWork W2049045266 @default.
• W2800876720 hasRelatedWork W2059076010 @default.
• W2800876720 hasRelatedWork W2082053935 @default.
• W2800876720 hasRelatedWork W2108724073 @default.

• next